Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

OSM Camerata among final six in international online competition
2017-08-28

 Description: OSM Camerata Tags: Odeion School of Music Camerata, International Ictus Music Competition, Stilian Kirov, ensembles, orchestras 

The Odeion School of Music Camerata at the University of
the Free State celebrated its fifth birthday in May 2017.
Photo: Supplied 

One of six – and the only contender from outside the United States of America. This is the extent of the achievement by the Odeion School of Music Camerata (OSMC) – one of six finalists in the 2017 International Ictus Music Competition.
The OSMC at the University of the Free State reached the final round of the competition, of which the winners will be announced on 1 September 2017. The competition is an innovative new online competition for ensembles, orchestras, and band/wind ensembles (middle school, high school, youth ensemble, community ensemble, and college/conservatory/university) that compete through video submission.

Odeion concert recorded as entry
The OSMC celebrated its fifth birthday on 31 May 2017, hosting a concert as part of the first round of the competition in the Odeion on the Bloemfontein Campus. The concert, which also served as a fundraising opportunity, consisted of a carefully curated concert programme which was recorded and submitted to the Ictus panel.

The repertoire for the concert, supported by a Concerts SA grant from the Samro Music Foundation, was commissioned from South African composers. Maestri Xavier Cloete and Gerhard de Jager served as conductors.

Substantial money prizes can be won, and ensembles will receive written feedback from a jury consisting of renowned maestri including Stilian Kirov, who was awarded 1st Prize in the Debut Berlin Competition on 18 May 2017. Top prize-winners will be interviewed and interviews will be broadcasted internationally.


Five years of many highlights

The OSMC was strategically founded in 2012 by Marius Coetzee as the OSM’s flagship chamber ensemble, with the main objective of creating a catalyst for excellence.

Over the past five years, the OSMC has premiered 15 new works by South African composers specially commissioned for them. A highlight remains its participation in the 13th International Conservatory Festival in St Petersburg Russia, where the ensemble received a standing ovation during a gala concert in the Glazunov Concert Hall.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept